{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15(2)"],"submitter":["Thida AM"],"pubmed_abstract":["<h4>Background</h4>To evaluate trends in allogeneic hematopoietic cell transplant (HCT) referral perceptions and practices, we compared surveys of Hematology-Oncology (Hem-Onc) physicians conducted in 2015 (N = 150), 2019 (N = 302), and 2024 (N = 183) and reported changes over time.<h4>Methods</h4>Eligible participants included Hem-Onc physicians in the United States seeing at least 10 hematologic malignancy patients in the last year. Questions covered perceptions of HCT, referral practices, perceived barriers to referral, and endorsement of HCT education and patient support resources.<h4>Results</h4>There were positive trends in HCT perceptions, increased expected HCT benefit, and positive outcomes with older AML patients. Overall reported disease-specific referral rates increased over th"],"journal":["Cancer medicine"],"pagination":["e71551"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12853074"],"repository":["biostudies-literature"],"pubmed_title":["Trends in US Hematology/Oncology Physician Perceptions and Referral Practices for Hematopoietic Cell Transplant: A National Survey Conducted by NMDP."],"pmcid":["PMC12853074"],"pubmed_authors":["Watters S","Devine S","Duan M","Shah A","Steffens KF","Vadaparampil ST","Thida AM","Pidala J"],"additional_accession":[]},"is_claimable":false,"name":"Trends in US Hematology/Oncology Physician Perceptions and Referral Practices for Hematopoietic Cell Transplant: A National Survey Conducted by NMDP.","description":"<h4>Background</h4>To evaluate trends in allogeneic hematopoietic cell transplant (HCT) referral perceptions and practices, we compared surveys of Hematology-Oncology (Hem-Onc) physicians conducted in 2015 (N = 150), 2019 (N = 302), and 2024 (N = 183) and reported changes over time.<h4>Methods</h4>Eligible participants included Hem-Onc physicians in the United States seeing at least 10 hematologic malignancy patients in the last year. Questions covered perceptions of HCT, referral practices, perceived barriers to referral, and endorsement of HCT education and patient support resources.<h4>Results</h4>There were positive trends in HCT perceptions, increased expected HCT benefit, and positive outcomes with older AML patients. Overall reported disease-specific referral rates increased over th","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Feb","modification":"2026-06-13T05:30:16.482Z","creation":"2026-06-13T03:09:10.257Z"},"accession":"S-EPMC12853074","cross_references":{"pubmed":["41607247"],"doi":["10.1002/cam4.71551"]}}